View Item 

Show simple item record

Depot Medroxyprogesterone Acetate Use and Periodontal Health in 15‐ to 44‐Year‐Old US Females

dc.contributor.authorTaichman, L. Susan
dc.contributor.authorSohn, Woosung
dc.contributor.authorKolenic, Giselle
dc.contributor.authorSowers, MaryFran
dc.date.accessioned2018-02-05T16:26:31Z
dc.date.available2018-02-05T16:26:31Z
dc.date.issued2012-08
dc.identifier.citationTaichman, L. Susan; Sohn, Woosung; Kolenic, Giselle; Sowers, MaryFran (2012). "Depot Medroxyprogesterone Acetate Use and Periodontal Health in 15‐ to 44‐Year‐Old US Females." Journal of Periodontology 83(8): 1008-1017.
dc.identifier.issn0022-3492
dc.identifier.issn1943-3670
dc.identifier.urihttps://hdl.handle.net/2027.42/141038
dc.publisherWiley Periodicals, Inc.
dc.publisherAmerican Academy of Periodontology
dc.subject.othergingivitis
dc.subject.otherperiodontitis
dc.subject.otherpublic health
dc.subject.otherwomen’s health
dc.subject.otherEpidemiology
dc.subject.othermedroxyprogesterone acetate
dc.titleDepot Medroxyprogesterone Acetate Use and Periodontal Health in 15‐ to 44‐Year‐Old US Females
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelDentistry
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI.
dc.contributor.affiliationumCenter for Statistical Consultation and Research, University of Michigan, Ann Arbor, MI.
dc.contributor.affiliationotherDeceased; previously, Department of Epidemiology, School of Public Health, Ann Arbor, MI.
dc.contributor.affiliationotherDepartment of Health Policy and Health Services Research, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA.
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141038/1/jper1008.pdf
dc.identifier.doi10.1902/jop.2012.110534
dc.identifier.sourceJournal of Periodontology
dc.identifier.citedreferenceBrown LJ, Löe H. Prevalence, extent, severity and progression of periodontal disease. Periodontol 2000 1993; 2: 57 – 71.
dc.identifier.citedreferenceBelsey EM. Menstrual bleeding patterns in untreated women and with long‐acting methods of contraception. Task Force on Long‐Acting Systemic Agents for Fertility Regulation. Adv Contracept 1991; 7: 257 – 270.
dc.identifier.citedreferenceKaunitz AM, Portman DJ, Hait H, Reape KZ. Adding low‐dose estrogen to the hormone‐free interval: Impact on bleeding patterns in users of a 91‐day extended regimen oral contraceptive. Contraception 2009; 79: 350 – 355.
dc.identifier.citedreferenceJeppsson S, Gershagen S, Johansson ED, Rannevik G. Plasma levels of medroxyprogesterone acetate (MPA), sex‐hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long‐term use of depo‐MPA (Depo‐Provera) as a contraceptive agent. Acta Endocrinol (Copenh) 1982; 99: 339 – 343.
dc.identifier.citedreferenceClark MK, Sowers M, Levy B, Nichols S. Bone mineral density loss and recovery during 48 months in first‐time users of depot medroxyprogesterone acetate. Fertil Steril 2006; 86: 1466 – 1474.
dc.identifier.citedreferenceClark MK, Sowers MR, Nichols S, Levy B. Bone mineral density changes over two years in first‐time users of depot medroxyprogesterone acetate. Fertil Steril 2004; 82: 1580 – 1586.
dc.identifier.citedreferenceKaunitz AM, Arias R, McClung M. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use. Contraception 2008; 77: 67 – 76.
dc.identifier.citedreferenceRenner RM, Edelman AB, Kaunitz AM. Depot medroxyprogesterone acetate contraceptive injections and skeletal health. Womens Health (Lond Engl) 2010; 6: 339 – 342.
dc.identifier.citedreferenceCromer BA, Scholes D, Berenson A, et al. Depot medroxyprogesterone acetate and bone mineral density in adolescents—The Black Box Warning: A Position Paper of the Society for Adolescent Medicine. J Adolesc Health 2006; 39: 296 – 301.
dc.identifier.citedreferenceTilakaratne A, Soory M, Ranasinghe AW, Corea SM, Ekanayake SL, de Silva M. Periodontal disease status during pregnancy and 3 months post‐partum, in a rural population of Sri‐Lankan women. J Clin Periodontol 2000; 27: 787 – 792.
dc.identifier.citedreferenceTilakaratne A, Soory M. Androgen metabolism in response to oestradiol‐17beta and progesterone in human gingival fibroblasts (HGF) in culture. J Clin Periodontol 1999; 26: 723 – 731.
dc.identifier.citedreferenceTilakaratne A, Soory M. Modulation of androgen metabolism by estradiol‐17beta and progesterone, alone and in combination, in human gingival fibroblasts in culture. J Periodontol 1999; 70: 1017 – 1025.
dc.identifier.citedreferenceAbma JC, Martinez GM, Mosher WD, Dawson BS. Teenagers in the United States: Sexual activity, contraceptive use, and childbearing, 2002. Vital Health Stat 23 2004; ( 24 ): 1 – 48.
dc.identifier.citedreferenceAbma JC, Sonenstein FL. Sexual activity and contraceptive practices among teenagers in the United States, 1988 and 1995. Vital Health Stat 23 2001; ( 21 ): 1 – 79.
dc.identifier.citedreferencePinkston Koenigs LM, Miller NH. The contraceptive use of Depo‐Provera in U.S. adolescents. J Adolesc Health 1995; 16: 347 – 349.
dc.identifier.citedreferenceCenters for Disease Control and Prevention (CDC). National Health and Nutrition Examination operations. Survey Questionnaires, Examination Components and Laboratory Components 1999‐2000. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011. Available at: http://www.cdc.gov/nchs/data/nhanes/crhq.pdf. Accessed November 5, 2011.
dc.identifier.citedreferenceDye BA, Barker LK, Selwitz RH, et al. Overview and quality assurance for the National Health and Nutrition Examination Survey (NHANES) oral health component, 1999‐2002. Community Dent Oral Epidemiol 2007; 35: 140 – 151.
dc.identifier.citedreferenceDye BA, Nowjack‐Raymer R, Barker LK, et al. Overview and quality assurance for the oral health component of the National Health and Nutrition Examination Survey (NHANES), 2003‐04. J Public Health Dent 2008; 68: 218 – 226.
dc.identifier.citedreferenceTsakos G, Sabbah W, Hingorani AD, et al. Is periodontal inflammation associated with raised blood pressure? Evidence from a National US survey. J Hypertens 2010; 28: 2386 – 2393.
dc.identifier.citedreferenceU.S. Department of Health and Human Services. National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988‐94, Plan and Operations Procedures Manuals (CD‐ROM). Hyattsville, MD: Centers for Disease Control and Prevention; 1996.
dc.identifier.citedreferenceU.S. Department of Health and Human Services. United States Food and Drug Administration. Safety Alerts for Human Medical Products. Depo‐Provera (medroxyprogesterone acetate injectable suspension); 2004. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154784.htm. Accessed November 5, 2011.
dc.identifier.citedreferenceViola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L. A cross‐sectional study of the forearm bone mineral density in long‐term current users of the injectable contraceptive depot medroxyprogesterone acetate. Contraception 2011; 84: e31 – e37.
dc.identifier.citedreferenceHarel Z, Johnson CC, Gold MA, et al. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception 2010; 81: 281 – 291.
dc.identifier.citedreferencevan der Weijden GA, de Slegte C, Timmerman MF, van der Velden U. Periodontitis in smokers and non‐smokers: Intra‐oral distribution of pockets. J Clin Periodontol 2001; 28: 955 – 960.
dc.identifier.citedreferenceBrunner Huber LR, Huber KR. Contraceptive choices of women 35‐44 years of age: Findings from the behavioral risk factor surveillance system. Ann Epidemiol 2009; 19: 823 – 833.
dc.identifier.citedreferenceBhat M. Periodontal health of 14‐17‐year‐old US schoolchildren. J Public Health Dent 1991; 51: 5 – 11.
dc.identifier.citedreferenceEke PI, Thornton‐Evans GO, Wei L, Borgnakke WS, Dye BA. Accuracy of NHANES periodontal examination protocols. J Dent Res 2010; 89: 1208 – 1213.
dc.identifier.citedreferenceKazerooni T, Ghaffarpasand F, Rastegar N, Kazerooni Y. Effect of levonorgestrel implants on the periodontium. Int J Gynaecol Obstet 2008; 103: 255 – 256.
dc.identifier.citedreferenceSooriyamoorthy M, Gower DB. Hormonal influences on gingival tissue: Relationship to periodontal disease. J Clin Periodontol 1989; 16: 201 – 208.
dc.identifier.citedreferenceHaerian‐Ardakani A, Moeintaghavi A, Talebi‐Ardakani MR, Sohrabi K, Bahmani S, Dargahi M. The association between current low‐dose oral contraceptive pills and periodontal health: A matched‐case‐control study. J Contemp Dent Pract 2010; 11 ( 3 ): 33 – 40.
dc.identifier.citedreferenceMullally BH, Coulter WA, Hutchinson JD, Clarke HA. Current oral contraceptive status and periodontitis in young adults. J Periodontol 2007; 78: 1031 – 1036.
dc.identifier.citedreferencePreshaw PM, Knutsen MA, Mariotti A. Experimental gingivitis in women using oral contraceptives. J Dent Res 2001; 80: 2011 – 2015.
dc.identifier.citedreferenceTaichman LS, Eklund SA. Oral contraceptives and periodontal diseases: Rethinking the association based upon analysis of National Health and Nutrition Examination Survey data. J Periodontol 2005; 76: 1374 – 1385.
dc.identifier.citedreferenceSeck‐Diallo A, Cissé ML, Benoist HM, et al. Periodontal status in a sample of Senegalese women using hormonal contraception (in French). Odontostomatol Trop 2008; 31: 36 – 42.
dc.identifier.citedreferenceTilakaratne A, Soory M, Ranasinghe AW, Corea SM, Ekanayake SL, de Silva M. Effects of hormonal contraceptives on the periodontium, in a population of rural Sri‐Lankan women. J Clin Periodontol 2000; 27: 753 – 757.
dc.identifier.citedreferenceLapp CA, Thomas ME, Lewis JB. Modulation by progesterone of interleukin‐6 production by gingival fibroblasts. J Periodontol 1995; 66: 279 – 284.
dc.identifier.citedreferenceMiyagi M, Morishita M, Iwamoto Y. Effects of sex hormones on production of prostaglandin E2 by human peripheral monocytes. J Periodontol 1993; 64: 1075 – 1078.
dc.identifier.citedreferenceOjanotko‐Harri AO, Harri MP, Hurttia HM, Sewón LA. Altered tissue metabolism of progesterone in pregnancy gingivitis and granuloma. J Clin Periodontol 1991; 18: 262 – 266.
dc.identifier.citedreferenceAbraham‐Inpijn L, Polsacheva OV, Raber‐Durlacher JE. The significance of endocrine factors and microorganisms in the development of gingivitis in pregnant women (in Russian). Stomatologia (Mosk) 1996; 75: 15 – 18.
dc.identifier.citedreferenceLindhe J, Attström R, Björn AL. Influence of sex hormones on gingival exudation in gingivitis‐free female dogs. J Periodontal Res 1968; 3: 273 – 278.
dc.identifier.citedreferenceLindhe J, Brånemark PI, Lundskog J. Changes in vascular proliferation after local application of sex hormones. J Periodontal Res 1967; 2: 266 – 272.
dc.identifier.citedreferenceChandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: Data from the 2002 National Survey of Family Growth. Vital Health Stat 23 2005; (25): 1 – 160.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jper1008.pdf
Size:
572.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.